Ana Aventín

879 total citations
18 papers, 610 citations indexed

About

Ana Aventín is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ana Aventín has authored 18 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Ana Aventín's work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Ana Aventín is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Ana Aventín collaborates with scholars based in Spain, Italy and Belgium. Ana Aventín's co-authors include Roberta La Starza, Cristina Mecucci, Maria Paola Martelli, Herman Van den Berghe, Iwona Włodarska, Peter Marynen, Teresa Vallespı́, Roberto Rosati, C Mecucci and Christine Schwienbacher and has published in prestigious journals such as Blood, The Journal of Pathology and British Journal of Haematology.

In The Last Decade

Ana Aventín

18 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Aventín Spain	11	350	339	148	94	56	18	610
Dominique Mühlematter Switzerland	14	212 0.6×	365 1.1×	160 1.1×	130 1.4×	53 0.9×	25	528
D. C. van der Plas Netherlands	8	192 0.5×	344 1.0×	147 1.0×	99 1.1×	45 0.8×	11	498
Hendrati Pirc‐Danoewinata Austria	13	219 0.6×	311 0.9×	94 0.6×	146 1.6×	37 0.7×	24	495
Jastinder Sohal United Kingdom	11	408 1.2×	452 1.3×	200 1.4×	113 1.2×	173 3.1×	19	772
Patrik Andreasson Sweden	9	141 0.4×	259 0.8×	99 0.7×	179 1.9×	69 1.2×	13	425
Makoto Futaki Japan	13	325 0.9×	217 0.6×	116 0.8×	57 0.6×	43 0.8×	26	561
JL Laï France	5	232 0.7×	417 1.2×	162 1.1×	102 1.1×	17 0.3×	12	525
Audrey Basinko France	13	217 0.6×	242 0.7×	118 0.8×	108 1.1×	27 0.5×	33	512
Colin Grace United Kingdom	13	158 0.5×	252 0.7×	188 1.3×	55 0.6×	94 1.7×	20	463
Mauro Nanni Italy	16	402 1.1×	456 1.3×	294 2.0×	112 1.2×	97 1.7×	43	804

Countries citing papers authored by Ana Aventín

Since Specialization

Citations

This map shows the geographic impact of Ana Aventín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Aventín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Aventín more than expected).

Fields of papers citing papers by Ana Aventín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Aventín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Aventín. The network helps show where Ana Aventín may publish in the future.

Co-authorship network of co-authors of Ana Aventín

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Aventín. A scholar is included among the top collaborators of Ana Aventín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Aventín. Ana Aventín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Nomdedéu, Josep, Montserrat Hoyos, Jordi Esteve, et al.. (2012). Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group. Leukemia Research. 36(8). 990–997. 32 indexed citations

2.

Cervera, José, Pau Montesinos, José‐Ángel Hernández‐Rivas, et al.. (2009). Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Haematologica. 95(3). 424–431. 50 indexed citations

3.

Aventín, Ana, Roberta La Starza, Sandra Casas, et al.. (2003). MLL tandem duplication in two cases of acute myelocytic leukemia with unbalanced translocations. Cancer Genetics and Cytogenetics. 142(1). 8–12. 4 indexed citations

4.

Domingo‐Doménech, Eva, et al.. (2002). Novel dic(16;18)(q11;p11) in two cases of Philadelphia chromosome positive acute B-cell lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 139(1). 63–66. 1 indexed citations

5.

Martini, Alessandra Cadete, Roberta La Starza, Hilde Janssen, et al.. (2002). Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.. PubMed. 62(19). 5408–12. 85 indexed citations

6.

Rosati, Roberto, Roberta La Starza, Angelo Veronese, et al.. (2002). NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood. 99(10). 3857–3860. 153 indexed citations

7.

Millá, Fuensanta, Albert Oriol, José‐Luis González de Aguilar, et al.. (2001). Usefulness and Reproducibility of Cytomorphologic Evaluations to Differentiate Myeloma From Monoclonal Gammopathies of Unknown Significance. American Journal of Clinical Pathology. 115(1). 127–135. 13 indexed citations

8.

Cools, Jan, Pieter J. Peeters, Thierry Voet, et al.. (1999). Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia. Cytogenetic and Genome Research. 85(3-4). 260–266. 16 indexed citations

9.

Aventín, Ana, Roberta La Starza, Carmen Martínez‐Graciá, et al.. (1999). Involvement of MLL Gene in a t(10;11)(q22;q23) and a t(8;11)(q24;q23) Identified by Fluorescence In Situ Hybridization. Cancer Genetics and Cytogenetics. 108(1). 48–52. 8 indexed citations

10.

Starza, Roberta La, Iwona Włodarska, Ana Aventín, et al.. (1998). Molecular Delineation of 13q Deletion Boundaries in 20 Patients With Myeloid Malignancies. Blood. 91(1). 231–237. 50 indexed citations

11.

Starza, Roberta La, Iwona Włodarska, Ana Aventín, et al.. (1998). Molecular Delineation of 13q Deletion Boundaries in 20 Patients With Myeloid Malignancies. Blood. 91(1). 231–237. 44 indexed citations

12.

Starza, Roberta La, Ana Aventín, D Falzetti, et al.. (1996). 14Q+ CHROMOSOME MARKER IN A T-CELL-RICH B-CELL LYMPHOMA. The Journal of Pathology. 178(2). 227–231. 9 indexed citations

13.

Włodarska, Iwona, C Mecucci, Peter Marynen, et al.. (1995). TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood. 85(10). 2848–2852. 90 indexed citations

14.

Włodarska, Iwona, C Mecucci, Ana Aventín, et al.. (1994). FISH analysis of typical t(5;12) (q32;p12) and variant t(10;12)(q23;p12) translocation in four patients with chronic myeloid disorders. British Journal of Haematology. 87. 203. 4 indexed citations

15.

Speleman, Frank, Kathelijne Mangelschots, M. Vercruyssen, et al.. (1991). Analysis of whole-arm translocations in malignant blood cells by nonisotopic in situ hybridization. Cytogenetic and Genome Research. 56(1). 14–17. 17 indexed citations

16.

Aventín, Ana, Cristina Mecucci, Angeline Van Orshoven, André Delannoy, & Herman Van den Berghe. (1989). VARIANT (3:21) TRANSLOCATION AND MEGAKARYOCYTIC INVOLVEMENT IN BLASTIC CRISIS OF PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA. British Journal of Haematology. 71(4). 562–564. 7 indexed citations

17.

Mecucci, Cristina, Lucien Noens, Ana Aventín, Nicoletta Testoni, & Herman Van den Berghe. (1988). Philadelphia‐positive acute myelomonocytic leukemia with inversion of chromosome 16 and eosinobasophils. American Journal of Hematology. 27(1). 69–71. 20 indexed citations

18.

Aventín, Ana, Cristina Mecucci, & Herman Van den Berghe. (1988). Blastic phase of Ph1-positive chronic myeloid leukemia and t(3;21) [letter]. Blood. 72(1). 369–369. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact